home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9604b.zip
/
M9640783.TXT
< prev
next >
Wrap
Text File
|
1996-03-04
|
3KB
|
49 lines
Document 0783
DOCN M9640783
TI Synchronous presentation of Epstein-Barr virus-associated Hodgkin's
disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an
endemic area of ATLL.
DT 9604
AU Hayashi T; Yamabe H; Haga H; Akasaka T; Kadowaki N; Ohno H; Okuma M;
Fukuhara S; Department of Internal Medicine, Kyoto University, Japan.
SO Int J Hematol. 1995 Jun;61(4):215-22. Unique Identifier : AIDSLINE
MED/96164754
AB We report a patient from an endemic area of adult T-cell
leukemia/lymphoma (ATLL), who developed lymphoma with features
characteristic of Hodgkin's disease (HD). Large atypical
Reed-Sternberg/Hodgkin's cells (RS/H cells) had a
CD3-CD15+CD20-CD30+CD45RO- immunophenotype. Epstein-Barr virus (EBV)
latent membrane protein and EBV-encoded small RNA were detected in the
RS/H cells. The patient received C-MOPP/ABVD chemotherapy for the HD
resulting in a partial response. However, relapse occurred and he died
of disease progression associated with serious bacterial infection.
Although serial lymph node biopsies revealed consistent presence of the
EBV-positive RS/H cells, the background small lymphocytes showed
progressive increase in pleomorphism and nuclear irregularity. The
lymphocytes had the T-cell phenotype, CD3+CD4+CD7-CD8-. Southern blot
analysis using DNA probes for the human T-cell lymphotrophic virus-I
(HTLV-I) and the T-cell receptor beta-chain gene demonstrated expansion
of the HTLV-I infected monoclonal T-cells with the disease progression.
We concluded that the patient synchronously presented two independent
lymphoproliferative disorders; EBV-associated HD and ATLL resulting from
HTLV-I infection.
DE Antigens, CD/ANALYSIS Antineoplastic Agents, Combined/ADVERSE
EFFECTS/THERAPEUTIC USE Bleomycin/ADMINISTRATION & DOSAGE Case Report
Cyclophosphamide/ADMINISTRATION & DOSAGE Dacarbazine/ADMINISTRATION &
DOSAGE Doxorubicin/ADMINISTRATION & DOSAGE Fatal Outcome
Herpesviridae Infections/*COMPLICATIONS/VIROLOGY Herpesvirus 4,
Human/*ISOLATION & PURIF Hodgkin's Disease/*COMPLICATIONS/DRUG THERAPY
Human HTLV-I/*ISOLATION & PURIF Immunophenotyping Japan/EPIDEMIOLOGY
Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated/
*COMPLICATIONS/EPIDEMIOLOGY Lymph Nodes/PATHOLOGY Male Middle Age
Prednisone/ADMINISTRATION & DOSAGE Procarbazine/ADMINISTRATION & DOSAGE
Reed-Sternberg Cells/CHEMISTRY/VIROLOGY RNA, Viral/ANALYSIS Support,
Non-U.S. Gov't Tumor Stem Cells/CHEMISTRY Tumor Virus
Infections/*COMPLICATIONS/VIROLOGY Vincristine/ADMINISTRATION & DOSAGE
Viral Matrix Proteins/ANALYSIS Virus Activation/DRUG EFFECTS JOURNAL
ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).